Physician profile

David Shau

Orthopaedic Surgery · Fort Worth, TX

NPI 1366839326

$71,456.08

in general payments reported to CMS, 2019-2025

35 companies · $39K in 2025

The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$28,716.50
Travel and Lodging$17,207.58
Food and Beverage$8,266.94
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$6,672.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medical Device Business Services, INC. $21,514.21 2022-2025 Velys, Attune, Actis
Uoc USA INC $20,564.00 2022-2025 U2, Conformity, U-Motion II and Ustar II, Psa, U-Star II, U2
Acera Surgical, INC. $8,807.64 2025 Restrata Wound Matrix
Stryker Corporation $7,342.77 2021-2025 Mako
Depuy Synthes Products, INC. $5,764.81 2022-2025 Kincise
Heraeus Medical, LLC. $2,492.06 2022-2025 Palacos
Depuy Synthes Sales INC. $889.66 2021-2025 Na, Monovisc
Shalby Advanced Technologies, INC. $696.25 2024-2025 Consensus Knee System, Cks - Vitalite, Cs2 Acet. Cup Sys. - Vitalite
Kyocera Medical Technologies, INC. $319.33 2023
Davol INC. $288.85 2024-2025 Channel Drain, Arista, Surgiphor
Vertex Pharmaceuticals Incorporated $263.26 2024-2025
Smith+Nephew, INC. $223.29 2021-2025 Real Intelligence, Pico 7, Trigen Intertan
Oxford Performance Materials, INC. $219.00 2025
Pylant Medical $206.93 2025
Corentec America INC $193.48 2024
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Intellijoint Surgical INC. $174.49 2024 Intellijoint
Pacira Pharmaceuticals Incorporated $170.18 2021-2024 Iovera, Zilretta, Exparel
Zimmer Biomet Holdings, INC. $152.40 2022
Medacta USA, INC. $146.10 2023 Gmk Sphere
Nalu Medical, INC. $142.03 2025 Nalu Neurostimulation System
Convatec INC. $136.24 2023
Next Science LLC $131.50 2024 Blastx, Surgx, Xperience
Innovation Technologies INC $102.95 2025 Irrisept
Ferring Pharmaceuticals INC. $88.63 2023-2025 Euflexxa
Maxx Orthopedics, INC. $87.03 2023
Orthalign INC $70.81 2025 Orthalign Plus
Biocomposites INC $48.71 2023 Stimulan
Kinamed, INC. $40.53 2023
Ethicon US, LLC $35.81 2023-2025 Vistaseal, Dermabond Prineo
Medtronic, INC. $35.69 2023-2024 Aquamantys(Tm)
Bioventus LLC $25.91 2025 Exogen Ultrasound Bone Healing System
Nevro Corp. $25.60 2023 Senza
Si-Bone, INC. $23.65 2022
Heron Therapeutics, INC. $18.21 2022
Curonix LLC $14.07 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Shau

$71,456.08

in general payments reported 2019-2025

Years
2021-2025
Top company
Medical Device Business Services, INC.
Context
The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/9945291/david-shau

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.